Working… Menu

A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02499497
Recruitment Status : Active, not recruiting
First Posted : July 16, 2015
Last Update Posted : November 6, 2019
National Institute of Nursing Research (NINR)
Information provided by (Responsible Party):
Shalender Bhasin, MD, Dana-Farber Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : November 2022